Transaction #31306 · Form 4 · 0001825009-26-000003
CalciMedica, Inc. · Stock award · Director Stock Option (Right to Buy)
CalciMedica, Inc. · Transacted October 1, 2026 · Filed October 5, 2026
What does this filing report?
An SEC Form 4 filing for CalciMedica, Inc. records a stock award involving Director Stock Option (Right to Buy) on October 1, 2026. The reported quantity was 20,000. The filing date is October 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CalciMedica, Inc.
- Company CIK
- 0001534133
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 20,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 20,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 5, 2026, 5:24 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Guerard Frederic ↗
Director
CIK 0001825009
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 20,000
- Conversion / exercise price
- 1.64
- Exercise date
- Not reported
- Expiration date
- September 30, 2036
Filing footnotes & remarks
- F1
- Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.